Research Output per year
Fingerprint Dive into the research topics where Nobuyuki Tanaka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 20 Similar Profiles
Urinary Bladder Neoplasms
Medicine & Life Sciences
Carcinoma
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Recurrence
Medicine & Life Sciences
Renal Cell Carcinoma
Medicine & Life Sciences
Prostatic Neoplasms
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Platinum
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2007 2019
1
Citation
(Scopus)
Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma
Ito, K., Masunaga, A., Tanaka, N., Mizuno, R., Shirotake, S., Yasumizu, Y., Ito, Y., Miyazaki, Y., Hagiwara, M., Kanao, K., Mikami, S., Momma, T., Masuda, T., Nakagawa, K., Oyama, M., Asano, T. & Oya, M., 2019 Jan 1, In : Japanese Journal of Clinical Oncology. 49, 1, p. 69-76 8 p.Research output: Contribution to journal › Article
Disease-Free Survival
L-Lactate Dehydrogenase
Neutrophils
Lymphocytes
Therapeutics
1
Citation
(Scopus)
Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients
Takamatsu, K., Mizuno, R., Tanaka, N., Takeda, T., Morita, S., Matsumoto, K., Kosaka, T., Shinojima, T., Kikuchi, E., Asanuma, H., Oyama, M., Mikami, S. & Oya, M., 2019 Jan 1, In : International Journal of Clinical Oncology.Research output: Contribution to journal › Article
Renal Cell Carcinoma
C-Reactive Protein
Blood Proteins
Therapeutics
Molecular Targeted Therapy
Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy
Kaneko, G., Shirotake, S., Nishimoto, K., Miyazaki, Y., Ito, K., Ito, Y., Hagiwara, M., Kanao, K., Nakagawa, K., Momma, T., Asano, T., Tanaka, N., Mizuno, R., Oya, M. & Oyama, M., 2019 Aug 1, In : Japanese journal of clinical oncology. 49, 8, p. 780-785 6 p.Research output: Contribution to journal › Article
Renal Cell Carcinoma
Molecular Targeted Therapy
Therapeutics
Survival
Sirolimus
The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy
Takamatsu, K., Matsumoto, K., Shojo, K., Tanaka, N., Takeda, T., Morita, S., Kosaka, T., Mizuno, R., Shinojima, T., Kikuchi, E., Asanuma, H. & Oya, M., 2019 Jan 1, In : Urologic Oncology: Seminars and Original Investigations.Research output: Contribution to journal › Article
Prostatectomy
Prostatic Neoplasms
Recurrence
Neoplasms
Patient Transfer
1
Citation
(Scopus)
TNFAIP2 expression induces epithelial-to-mesenchymal transition and confers platinum resistance in urothelial cancer cells
Niwa, N., Tanaka, N., Hongo, H., Miyazaki, Y., Takamatsu, K., Mizuno, R., Kikuchi, E., Mikami, S., Kosaka, T. & Oya, M., 2019 Jan 1, In : Laboratory Investigation.Research output: Contribution to journal › Article
Epithelial-Mesenchymal Transition
Platinum
Carcinoma
Neoplasms
Cadherins